FGF21-mediated improvements in cardiomyocyte hypertrophy (Fig. 6f and g) and fibrosis (Fig. 6f and h) were also restrained in T1D mice after LAT1 overexpression. Here, FGF21 is linked to type 1 diabetes mellitus.